Your browser doesn't support javascript.
loading
Multi-omics approaches identify SF3B3 and SIRT3 as candidate autophagic regulators and druggable targets in invasive breast carcinoma.
Zhang, Shouyue; Zhang, Jin; An, Yang; Zeng, Xiaoxi; Qin, Ziyi; Zhao, Yuqian; Xu, Heng; Liu, Bo.
Affiliation
  • Zhang S; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 61004, China.
  • Zhang J; Department of Laboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
  • An Y; State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 61004, China.
  • Zeng X; Department of Laboratory Medicine, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
  • Qin Z; School of Pharmaceutical Sciences, Health Science Center, Shenzhen University, Shenzhen 518060, China.
  • Zhao Y; Department of Plastic Surgery, Peking University Third Hospital, Beijing 100191, China.
  • Xu H; Division of Plastic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Liu B; West China Biomedical Big Data Center, West China Hospital, Sichuan University, Chengdu 610041, China.
Acta Pharm Sin B ; 11(5): 1227-1245, 2021 May.
Article in En | MEDLINE | ID: mdl-34094830
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Acta Pharm Sin B Year: 2021 Document type: Article Affiliation country: China Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Acta Pharm Sin B Year: 2021 Document type: Article Affiliation country: China Country of publication: Países Bajos